John V. Balen, Director at Cardlytics, Inc. (CDLX), bought 15,000 shares at $4.24 ($61K) on 2022-11-07, disclosed to the SEC on 2022-11-09.
Open-market purchase of $61k CDLX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.24 | 6,000 | $25K | 42.0% |
| 2 | $3.95 | 6,000 | $24K | 39.1% |
| 3 | $3.80 | 3,000 | $11K | 18.8% |
| Total | $4.04 avg | 15,000 | $61K | 100% |
| Filing → |
| CDLX | BUY | 2022-05-10 | $88K | — | Filing → |
| CDLX | BUY | 2021-08-31 | $90K | — | Filing → |
| CDLX | BUY | 2021-08-23 | $160K | — | Filing → |